Invention Grant
- Patent Title: Adjuvanted formulations of booster vaccines
- Patent Title (中): 佐剂配方的加强疫苗
-
Application No.: US13790948Application Date: 2013-03-08
-
Publication No.: US09375471B2Publication Date: 2016-06-28
- Inventor: Barbara Baudner , Derek O'Hagan , Manmohan Singh , Simone Bufali
- Applicant: Novartis AG
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals SA
- Current Assignee: GlaxoSmithKline Biologicals SA
- Current Assignee Address: BE Rixensart
- Agency: Morrison & Foerster LLP
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/00 ; A61K39/38 ; A61K39/39
Abstract:
The invention improves TdaP vaccines by including a TLR agonist in them. This agonist can provide stronger protection, longer-lasting protection, and/or can reduce the amount of antigen which is required to achieve a particular immune response.
Public/Granted literature
- US20130236492A1 ADJUVANTED FORMULATIONS OF BOOSTER VACCINES Public/Granted day:2013-09-12
Information query
